相关实验视频

Updated: Jan 15, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

介素-6作为感染并发症急性髓性白血病的首选预后因素

Natalia Bujko-Wasiak¹, Aleksandra Kaźmierczak², Łukasz Dariusz Lisak²

¹Department of Hematology, Faculty of Medicine and Health Science, University of Zielona Gora, Multi-Specialist Hospital Gorzow Wielkopolski, Poland.

Contemporary oncology (Poznan, Poland)

|October 16, 2025

概括

干白素-6 (IL-6) 在急性髓性白血病 (AML) 患者中有效预测感染严重程度和死亡率,其表现优于C反应蛋白 (CRP) 和前素 (PCT). 常规IL-6监测可以改善AML感染患者的结果.

科学领域:

血液学血液学血液学
传染性疾病传染性疾病
生物标志物研究生物标志物研究

背景情况:

急性髓性白血病 (AML) 患者极易患有严重的传染性并发症.
传统的炎症标记物,如C反应蛋白 (CRP) 和前素 (PCT),在预测AML感染结果方面存在局限性.

研究的目的:

调查介质素-6 (IL-6) 在预测AML患者感染严重程度和死亡率方面的预后意义.
为了比较IL-6对CRP和PCT在AML感染性并发症的预测性表现.

主要方法:

追溯分析了84名患有感染并发症的AML患者.
在感染开始时测量IL-6,CRP和PCT;感染严重程度的分级 (1-5).
统计分析包括相关性,ANOVA和多变量逻辑回归.

主要成果:

与CRP和PCT相比,IL-6与感染严重程度和死亡率 (OR2.45;95%CI:1.80-3.33) 的相关性最强.
IL-6表现出优越的预测能力,特别是在严重和致命的感染中,特别是在中年患者 (41-60岁).
随着感染严重程度的增加,CRP和PCT水平也增加了,但比IL-6更难预测.

结论:

IL-6是AML患者感染严重程度和死亡率的可靠预后生物标志物.
常规IL-6监测可以促进高风险患者的早期识别和及时干预.
将IL-6监测纳入标准护理方案可能会改善AML感染患者的治疗结果.

关键词:

在C-反应性蛋白 (CRP) 中.急性髓性白血病 (AML) 是一种疾病.血液学的恶性瘤.炎症标志物的炎症标志物互白素-6 (IL-6) 是一种蛋白质.这种药物被称为PCT (prokalcitonin).

更多相关视频

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

相关概念视频

Disorders of Leukocytes

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...